Quantum Private Wealth’s Viking Therapeutics VKTX Stock Holding History

Quantum Private Wealth’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.42M	Sell	105,135 -200	-0.2%	-$6.43K	1.06%	19
2025 Q4	$3.71M	Buy	105,335 +319	+0.3%	+$11.3K	1.08%	18
2025 Q3	$2.76M	Buy	105,016 +18,300	+21%	+$546K	0.81%	24
2025 Q2	$2.3M	Buy	86,716 +200	+0.2%	+$5.26K	0.74%	25
2025 Q1	$2.09M	Buy	86,516 +600	+0.7%	+$19K	0.79%	23
2024 Q4	$3.46M	Buy	85,916 +1,832	+2%	+$104K	1.11%	15
2024 Q3	$5.32M	Buy	84,084 +7,161	+9%	+$420K	1.8%	10
2024 Q2	$4.08M	Buy	76,923 +3,816	+5%	+$250K	1.45%	12
2024 Q1	$5.99M	Buy	73,107 +6,457	+10%	+$287K	2.22%	7
2023 Q4	$1.24M	Hold	66,650	–	–	0.52%	42
2023 Q3	$738K	Buy	66,650 +1,300	+2%	+$18.6K	0.35%	69
2023 Q2	$1.06M	Buy	65,350 +302	+0.5%	+$6.33K	0.49%	42
2023 Q1	$1.08M	Buy	65,048 +500	+0.8%	+$5.17K	0.59%	33
2022 Q4	$607K	Buy	64,548 +2,000	+3%	+$8.93K	0.38%	70
2022 Q3	$170K	Buy	62,548 +12,000	+24%	+$39.3K	0.11%	162
2022 Q2	$146K	Buy	50,548 +4,100	+9%	+$10.1K	0.09%	167
2022 Q1	$139K	Hold	46,448	–	–	0.06%	191
2021 Q4	$213K	Buy	+46,448	New	+$260K	0.08%	190

Other funds holding VKTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Quantum Private Wealth's VKTX Position: Q1 2026 in Review

Quantum Private Wealth reduced its Viking Therapeutics (VKTX) stake by 0.19% in Q1 2026, selling an estimated $6.43K and leaving 105,135 shares worth $3.42M. The position accounts for 1.06% of the portfolio, ranked #19.

Quantum Private Wealth first reported a position in VKTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.99M in Q1 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

Quantum Private Wealth held 105,135 shares of Viking Therapeutics worth $3.42M as of Q1 2026.
Quantum Private Wealth sold 200 Viking Therapeutics shares in Q1 2026, an estimated $6.43K.
Viking Therapeutics made up 1.06% of Quantum Private Wealth's portfolio in Q1 2026, its #19 holding.
Quantum Private Wealth first reported a position in Viking Therapeutics in Q4 2021 and has held it in 18 quarters since.
Quantum Private Wealth's Viking Therapeutics position peaked at $5.99M in Q1 2024.
410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Quantum Private Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.